Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bausch & Lomb Files 2006 Annual Report on Form 10-K.


ROCHESTER, N.Y. -- Bausch & Lomb (NYSE NYSE

See: New York Stock Exchange
:BOL BOL Bolivia (ISO Country code)
BOL Books Online
BOL Bole (SIL code, Nigeria)
BOL Bill Of Lading
BOL Beginning Of Line
BOL Best Of Luck
BOL Buzz Out Loud
BOL Bruin Online
BOL Beginning Of Life
) today is filing its Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 for the year ended December 30, 2006 (the "2006 10-K") with the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  Securities and Exchange Commission ("SEC"). The full text of the filing, which also includes executive compensation disclosures that typically would be included in the Company's proxy statement Proxy Statement

A document containing the information that a company is required by the SEC to provide to shareholders so they can make informed decisions about matters that will be brought up at an annual stockholder meeting.
, can be accessed through the Company's Internet site at http://www.bausch.com/en_US/corporate/ir/general/annual.aspx and on the SEC's Internet site at www.sec.gov.

Bausch & Lomb Senior Vice President and Chief Financial Officer Efrain Rivera said, "We're pleased to have made progress with our SEC filings." Rivera indicated that the filing of the 2006 10-K satisfied the Company's obligation to provide 2006 reports in connection with the financial reporting requirements under its bank credit facilities and public debt.

As noted in the 2006 10-K, Bausch & Lomb is working to finalize and file its outstanding Quarterly Reports on Form 10-Q Form 10-Q

See 10-Q.
 for the first, second and third quarters of 2006 and the third quarter of 2005. While the Company is working diligently to complete those filings, there can be no assurance as to when it will be current in its reporting obligations.

This news release contains, among other things, certain statements of a forward-looking nature relating to future events or the future business performance of Bausch & Lomb. Such statements involve a number of risks and uncertainties including those concerning the ability of the Company and the parties with which it contracts to develop and introduce products successfully as well as the risk factors listed from time to time in the Company's SEC filings, including but not limited to filings on Form 8-K Form 8-K

The form required by the SEC when a publicly held company incurs any event that might affect its financial situation or the share value of its stock.


Form 8-K

See 8-K.
 and on Form 12b-25, each dated November 9, 2006 and Form 10-K, dated April 25, 2007.

Bausch & Lomb is the eye health company, dedicated to perfecting vision and enhancing life for consumers around the world. Its core businesses include soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products. The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world. Founded in 1853, the Company is headquartered in Rochester, New York This article is about the city of Rochester in Monroe County. For the town in Ulster County, see Rochester, Ulster County, New York.
Rochester, once known as The Flour City, and more recently as The Flower City or
, and employs approximately 13,000 people worldwide. Its products are available in more than 100 countries. More information about the Company can be found on the Bausch & Lomb Internet site at www.bausch.com. Copyright Bausch & Lomb Incorporated.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 25, 2007
Words:406
Previous Article:NuStar GP Holdings, LLC Reports First Quarter 2007 Earnings and Announces Quarterly Distribution.
Next Article:Standards Support Pushes VaST's CoMET6 Deeper Into Embedded Supply Chain.
Topics:



Related Articles
Bausch & Lomb Provides Information Regarding U.S. Sales of ReNu(R) with MoistureLoc(R) Solution.
Bausch & Lomb Clarifies Reporting of Fusarium Keratitis Cases to FDA.
CDC Report Supports Bausch & Lomb's Decision to Recall MoistureLoc(R) Solution, Only Product Associated with Unusual Increase in Fusarium Infections.
Bausch & Lomb Receives IRS Notice of Administrative Adjustment for 1999 Tax Year; Will Petition Tax Court to Contest Adjustment.
Three new litigation groups join ATLA roster; another is revitalized.
Bausch & Lomb Receives FDA Warning Letter Related to Inspection at Greenville, S.C. Solutions Manufacturing Plant Conducted in March-May 2006.
Bausch & Lomb Obtains New York Stock Exchange Listing Extension.
Bausch & Lomb's Listing on New York Stock Exchange Extended.
Lawyers focus on lens solution lawsuits.
Bausch & Lomb Files Forms 10-Q for First Quarters of 2007 and 2006.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles